UW Medicine Division of Allergy and Infectious Diseases
Directory >> John D. Scott, MD, MSc


Contact Information

John D. Scott, MD, MSc

    Associate Professor, Medicine
    University of Washington
    Medical Director, Telehealth
    Associate Director,
    Hepatitis and Liver Clinic
    Harborview Medical Center

Dr. Scott's research focuses on viral hepatitis and the use of telehealth technologies to improve care of patients with Infectious Disease issues. Dr. Scott has an active research program with novel antivirals and diagnostics, in partnership with pharmaceutical companies. Along with Public Health Seattle King County, he is working on a CDC-funded initiative to increase diagnosis, linkage to care and treatment of patients with hepatitis C.

In 2009, he launched Project ECHO in Washington State. This innovative telehealth program helps clinicians serving in rural and underserved areas with the evaluation and treatment of hepatitis C, HIV/AIDS and tuberculosis. In 2013, he became the first medical director for telehealth at the UW. Research has focused on creating innovative learning platforms, in partnership with David Spach and Nina Kim through HCV Online.

Selected Publications

Scott JD, Gretch DR. Molecular diagnostics of hepatitis C virus infection: A systematic review; JAMA 2007; 297: 724-732.
PubMed Abstract

Scott JD, Holte S, Urban T, Burgess C, Coppel E, Wang C, Corey L, McHutchison J, Goldstein D.; IL28B genotype effects during early treatment with peginterferon and ribavirin in difficult to treat hepatitis C virus infection. J Infect Dis 2011; 204:419-25.
PubMed Abstract

Schiffer JT, Scott JD, Corey L. Fighting a defiant virus.  Nature Med 2011; 17:253-4.
Nature Medicine Abstract

Coffin P, Scott JD, Sullivan S, Golden M. Cost-effectiveness and population outcomes of general population screening for hepatitis C. ; Clin Infect Dis (in press).
PubMed Abstract

Scott JD, Unruh K, Catlin MC, et al. Project ECHO: A model for complex, chronic care in the pacific northwest of the United States. J Telemed Telecare. 2012; 18(8): 481-4.
PubMed Abstract

Ioannou GN, Bryson CL, Weiss NS, Miller R, Scott JD, Boyko EJ. The prevalence of cirrhosis and HCC in patients with HIV infection. Hepatology 2013; 57:249-57.
PubMed Abstract

Lawitz E, Sulkowski MS, Ghalib R, Rodriguez-Torres M, Younossi ZM, Corregidor A, DeJesus E, Pearlman B, Rabinovitz M, Gitlin N, Lim JK, Pockros PJ, Scott JD, Fevery B, Lambrecht T, Ouwerkerk-Mahadevan S, Callewaert K, Symonds WT, Picchio G, Lindsay KL, Beumont M, Jacobson IM. Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study. Lancet. 2014 Nov 15; 384(9956):1756-65
PubMed Abstract ]

to top